Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 51
LMI highlights research on PET neuroimaging tracers
By
AuntMinnie.com staff writers
Berlin-based Life Molecular Imaging (LMI) is unveiling new study findings on its PET neuroimaging tracers through nine different presentations at this week's Human Amyloid Imaging meeting in Miami.
January 15, 2020
ASRT: Enrollment down for radiologic technology programs
By
AuntMinnie.com staff writers
The number of students enrolling in radiologic technology programs trended downward in 2019, according to a report released by the American Society of Radiologic Technologists (ASRT).
January 14, 2020
Cu-64 DOTATATE PET could handle neuroendocrine tumors
By
Wayne Forrest
PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the
Journal of Nuclear Medicine
.
January 14, 2020
DOE waives export ban on highly enriched uranium
By
AuntMinnie.com staff writers
The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.
January 8, 2020
RadioMedix, Curium file NDA for PET agent
By
AuntMinnie.com staff writers
Biotechnology firm RadioMedix and global nuclear medicine firm Curium have filed a new drug application (NDA) with the U.S. Food and Drug Administration for the firms' PET diagnostic radiopharmaceutical copper-64 (Cu-64) DOTATATE.
January 7, 2020
Navidea claims victories in legal case with former CEO
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is claiming victories in several motions in a legal case pitting the company against its former CEO, Dr. Michael Goldberg.
January 2, 2020
Zr-89 immuno-PET could help predict cancer therapy outcomes
By
Wayne Forrest
Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the
Journal of Nuclear Medicine
.
December 17, 2019
Japanese partnership targets radiotherapeutics
By
AuntMinnie.com staff writers
Osaka University Graduate School of Medicine has signed a collaborative research agreement with Fuzionaire Diagnostics to develop anticancer radiotherapeutic agents.
December 12, 2019
Award recognizes key partnership in Mo-99 production
By
AuntMinnie.com staff writers
Eden Radioisotopes and Sandia National Laboratories together have received the 2019 Excellence in Technology Transfer award from the Federal Laboratory Consortium for their production of molybdenum-99 (Mo-99).
November 21, 2019
Revenue slips at International Isotopes in Q3
By
AuntMinnie.com staff writers
Revenue decreases in its cobalt products and radiological services segments hampered growth for radioisotope manufacturer International Isotopes in its third-quarter and nine-month financial report.
November 20, 2019
Canon to introduce new digital PET/CT scanner at RSNA 2019
By
AuntMinnie.com staff writers
Canon Medical Systems USA will unveil a new PET/CT scanner, called Cartesion Prime, at the upcoming RSNA 2019 meeting in Chicago.
November 18, 2019
Firms partner to meet global medical isotope needs
By
AuntMinnie.com staff writers
Four Canadian and European companies have signed partnership agreements to produce medical isotopes and create a new worldwide delivery system for them.
November 12, 2019
Previous Page
Page 51 of 440
Next Page